![]() |
市場調查報告書
商品編碼
1663034
癌症資訊系統市場規模、佔有率和成長分析(按產品/服務、應用、最終用戶和地區)- 產業預測 2025-2032Oncology Information Systems Market Size, Share, and Growth Analysis, By Product and Service (Software, Professional Services), By Application (Radiation Oncology, Medical Oncology), By End User, By Region - Industry Forecast 2025-2032 |
2023 年全球癌症資訊系統市場規模價值 72.1 億美元,預計將從 2024 年的 77.8 億美元成長到 2032 年的 142.9 億美元,預測期內(2025-2032 年)的複合年成長率為 7.9%。
癌症資訊系統 (OIS) 對醫院、診所和實驗室至關重要,它促進組織間的資料交換,以最佳化癌症治療並提高護理品質和病人安全。隨著政府對癌症研究和開發的資助不斷增加,對有效的患者資訊和資料管理解決方案的需求也日益成長,OIS 市場有望經歷顯著成長。需求的激增促使對各種 OIS 軟體包的投資以及創新技術的開發,尤其是在腫瘤學領域。此外,OIS 還透過全面的資料為臨床醫生提供支持,以便及時、精準地進行治療並評估治療結果。隨著醫療保健預算的擴大,投資 OIS 開發商提供了一個有利可圖的機會,以滿足對先進醫療規劃系統日益成長的需求。
Global Oncology Information Systems Market size was valued at USD 7.21 billion in 2023 and is poised to grow from USD 7.78 billion in 2024 to USD 14.29 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
Oncology Information Systems (OIS) are becoming crucial for hospitals, clinics, and research labs by optimizing cancer care and facilitating inter-organizational data exchange to enhance treatment quality and patient safety. With growing government funding for oncology research and development, the OIS market is poised for significant growth, driven by the increasing need for effective patient information and data management solutions. This surge in demand is prompting investments in diverse OIS software packages and the development of innovative technologies, particularly in the cancer sector. Additionally, OIS ensures timely and accurate treatment delivery, supporting clinicians with comprehensive data for evaluating treatment outcomes. As healthcare budgets expand, investing in leading OIS developers presents lucrative opportunities to meet the evolving demand for advanced medical planning systems.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oncology Information Systems Market Segments Analysis
Global Oncology Information Systems Market is segmented by Product and Service, Application, End User and region. Based on Product and Service, the market is segmented into Software and Professional Services. Based on Application, the market is segmented into Radiation Oncology, Medical Oncology and Surgical Oncology. Based on End User, the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions and Research Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Oncology Information Systems Market
The growing prevalence of cancer worldwide significantly propels the global oncology information systems market. The World Health Organization (WHO) highlights that cancer ranks among the foremost causes of mortality globally, underscoring the need for efficient treatment planning, data management, and patient care strategies. Oncology information systems enhance the functionality of oncology departments by enabling real-time information sharing, thereby increasing the precision of treatments. This improved accuracy not only optimizes patient outcomes but is also supported by advancements in pharmaceutical therapies. As such, the urgent demand for innovative solutions in cancer care continues to drive the market expansion for oncology information systems.
Restraints in the Global Oncology Information Systems Market
A significant challenge hindering the global adoption of Oncology Information Systems (OIS) is the substantial cost involved in their implementation and ongoing maintenance. Advanced OIS platforms necessitate considerable investments in infrastructure, software, and highly trained personnel, which can be a financial strain for smaller healthcare facilities, particularly in low- and middle-income countries. Additionally, the continuous need for maintenance, software updates, and robust cybersecurity measures further compounds these expenses, restricting the growth potential of the market in regions with limited resources. The high financial barrier poses a considerable restraint to the widespread acceptance and utilization of OIS in various healthcare environments.
Market Trends of the Global Oncology Information Systems Market
The global oncology information systems (OIS) market is witnessing a significant trend with the integration of artificial intelligence (AI) to enhance treatment accuracy and operational efficiency. AI-powered OIS can analyze extensive patient data, identify patterns, and forecast treatment outcomes, leading to more personalized and effective care. This technological advancement minimizes human error and accelerates decision-making, particularly in complex oncology cases. As demand for advanced cancer care grows, companies are heavily investing in AI capabilities to differentiate their offerings and gain a competitive edge in the market, driving the adoption of innovative solutions in oncology management worldwide.